UNH
55
2
MCD
54
4
DAL
80
3
O
30
-5
IVZ
52
6
HRL
30
-6
TMO
51
4
PM
60
-8
BAX
38
3
CI
52
7
PDCO
36
-2
SPG
48
-5
FSLR
57
8
PVH
57
2
FLR
59
4
EXR
46
-2
BBY
40
2
HCA
48
-2
AN
43
2
CAH
47
15
UNH
55
2
MCD
54
4
DAL
80
3
O
30
-5
IVZ
52
6
HRL
30
-6
TMO
51
4
PM
60
-8
BAX
38
3
CI
52
7
PDCO
36
-2
SPG
48
-5
FSLR
57
8
PVH
57
2
FLR
59
4
EXR
46
-2
BBY
40
2
HCA
48
-2
AN
43
2
CAH
47
15
Financhill
Back

Hikma Pharmaceuticals PLC 10K Form

Sell
43

HKMPF
Hikma Pharmaceuticals PLC

Last Price:
25.07
Seasonality Move:
0.12%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HKMPF News And Ratings

See the #1 stock for the next 7 days that we like better than HKMPF

HKMPF Financial Statistics

Sales & Book Value

Annual Sales: $2.88B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $9.94
Price / Book: 0

Profitability

EPS (TTM): 0.85000
Net Income (TTM): $190M
Gross Margin: $1.39B
Return on Equity: 8.69%
Return on Assets: 4.14%

Hikma Pharmaceuticals PLC Earnings Forecast

Key Hikma Pharmaceuticals PLC Financial Ratios

  • The Gross Profit Margin over the past 22 years for HKMPF is 48.35%.
  • The Selling, General & Administrative Expenses for HKMPF have been equal to 22.19% of Gross Profit Margin.
  • The Research & Development expenses have been 5.18% of Revenue.
  • The Interest Expense is 38.42% of Operating Income.
  • The Net Earning history of HKMPF is 6.61% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 13 years.

Hikma Pharmaceuticals PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: HKMPF
Website: hikma.com

Debt

Debt-to-Equity Ratio: 0.51
Current Ratio: 1.57
Quick Ratio: 0.82

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

HKMPF Technical Analysis vs Fundamental Analysis

Sell
43
Hikma Pharmaceuticals PLC (HKMPF) is a Sell

Is Hikma Pharmaceuticals PLC a Buy or a Sell?